Glucocorticoids are harmful in treating viral respiratory infections
Glucocorticoids are widely used in treating acute respiratory distress syndrome (ARDS) despite there being no indisputable scientific evidence of their effectiveness. …
Glucocorticoids are widely used in treating acute respiratory distress syndrome (ARDS) despite there being no indisputable scientific evidence of their effectiveness. …
Preliminary analysis of clinical trial data suggests the antiviral remdesivir shortens time to recovery in hospitalized COVID-19 patients with lower respiratory tract infection. …
The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, …
A large observational study finds hospitalized COVID-19 patients who received hydroxychloroquine or chloroquine had worse outcomes and heightened risk of ventricular arrhythmias. …
A large cohort study finds that age, male sex, obesity, and underlying illness are risk factors for severe COVID-19 and death in the UK. …
A newly developed membrane that can be attached to a regular N95 mask and replaced when needed, filters out SARS-CoV-2 virus while maintaining good breathability. …
Scientists from the UK, Europe, and the USA have published a consensus paper warning against high doses of vitamin D supplementation in preventing or treating COVID-19. …
Japanese immunologists propose a possible molecular mechanism for the massive release of proinflammatory cytokines, or cytokine storm, in COVID-19 patients. …
A pair of new studies demonstrate that candidate DNA vaccines protect rhesus macaques against COVID-19 and that prior SARS-CoV-2 infection protects against re-exposure. …
Treatment with antibodies purified from donated blood – immune globulin therapy – and steroids restored heart function in the majority of children with COVID-related …
End of content
End of content